Does ATORVASTATIN Cause Cerebral hypoperfusion? 42 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Cerebral hypoperfusion have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.1% of all adverse event reports for ATORVASTATIN.
42
Reports of Cerebral hypoperfusion with ATORVASTATIN
0.1%
of all ATORVASTATIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Cerebral hypoperfusion From ATORVASTATIN?
Of the 42 reports.
Is Cerebral hypoperfusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Cerebral hypoperfusion?
FUROSEMIDE (48)
CARBIDOPA\LEVODOPA (44)
RIVAROXABAN (44)
METFORMIN (43)
AMITRIPTYLINE (42)
APOMORPHINE (42)
BISACODYL (42)
DOMPERIDONE (42)
HUMAN IMMUNOGLOBULIN G (42)
PREGABALIN (42)
Which ATORVASTATIN Alternatives Have Lower Cerebral hypoperfusion Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM